Miscellaneous treatments, I: sulfasalazine and pentoxifylline: unapproved uses, dosages, or indications.
Wolf
Ronni
R
Dermatology Unit, Kaplan Medical Center, Rechovot, Israel. wolf_r@netvision.net.il
Matz
Hagit
H
Orion
Edith
E
Tüzün
Binnur
B
Tüzün
Yalcin
Y
D003879:Dermatologic Agents / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval; D004363:Drug Utilization; D005260:Female; D006801:Humans; D007557:Israel; D008297:Male; D010431:Pentoxifylline / Q000008:administration & dosage* / Q000009:adverse effects; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012460:Sulfasalazine / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014421:Turkey
D003879:Dermatologic Agents; D012460:Sulfasalazine; D010431:Pentoxifylline